Gut Microbiota and Probiotics in Alzheimer’s Disease: Mechanisms, Evidence, and Therapeutic Potential – A Review of Literature
DOI:
https://doi.org/10.12775/QS.2026.52.69093Keywords
Alzheimer’s disease, gut microbiota, gut microbiome, dysbiosis, gut-brain axisAbstract
Background: Alzheimer’s disease (AD) is the leading cause of dementia worldwide.
Despite advances in modern medicine, effective therapeutic strategies capable of preventing and treating patients suffering from AD are still being actively sought. Growing evidence suggests that the gut microbiota may play a significant role in the development and progression of AD through inflammatory, metabolic, and immune-mediated mechanisms.
Aim: This review aims to summarize current evidence regarding the association between
the gut microbiome, its metabolites, and Alzheimer’s disease, and to discuss potential therapeutic strategies targeting the gut microbiota in the prevention and management of AD.
Materials and Methods: The literature search was conducted using databases such as PubMed and Google Scholar. The following keywords were used: Alzheimer’s disease, gut microbiota, gut microbiome, dysbiosis, gut-brain axis.
Results: To date, the majority of findings suggest that modulation of gut microbiota composition through probiotic supplementation may represent a promising approach
for developing therapeutic and preventive strategies in Alzheimer’s disease. Probiotics appear effective in stabilizing or reconstructing gut microbial homeostasis, potentially delaying
the progression of neurodegenerative pathology. Nevertheless, a review of the literature reveals a deficit of clinical trials evaluating the effects of probiotic supplementation in individuals
with AD.
Conclusions: To date, prevailing evidence suggests that modulation of gut microbiota composition using probiotics constitutes a promising approach for the development
of therapeutic and preventive strategies in Alzheimer’s disease.
References
[1]. R Brookmeyer, S Gray, and C Kawas: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 88, 1337_1342, https://doi.org/10.2105/AJPH.88.9.1337
[2]. Zhang, X. X , Tian, Y , Wang, Z. T , Ma, Y. H , Tan, L , & Yu, J. T. (2021). The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention. The journal of prevention of Alzheimer's disease, 8(3), 313–321. https://doi.org/10.14283/jpad.2021.15
[3]. Toodayan N. (2016). Professor Alois Alzheimer (1864-1915): Lest we forget. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 31, 47–55. https://doi.org/10.1016/j.jocn.2015.12.032
[4]. Dcruz, Migita & Banerjee, Debanjan. (2022). The person is not the disease – Revisiting Alzheimer's dementia after 120 years. Journal of Geriatric Mental Health. 8. 136-138. Doi: 10.4103/jgmh.jgmh_39_21.https://www.researchgate.net/publication/358241431_The_person_is_not_the_disease_-_Revisiting_Alzheimer's_dementia_after_120_years
[5]. Brookmeyer, R , Johnson, E , Ziegler-Graham, K , & Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 3(3), 186–191. https://doi.org/10.1016/j.jalz.2007.04.381
[6]. Janoutová, J , Kovalová, M , Machaczka, O , Ambroz, P , Zatloukalová, A , Němček, K , & Janout, V. (2021). Risk Factors for Alzheimer's Disease: An Epidemiological Study. Current Alzheimer research, 18(5), 372–379. https://doi.org/10.2174/1567205018666210820124135
[7]. Liu, P. P , Xie, Y , Meng, X. Y , & Kang, J. S. (2019). History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal transduction and targeted therapy, 4, 29. https://doi.org/10.1038/s41392-019-0063-8
[8]. Arvanitakis, Z , Shah, R. C , & Bennett, D. A. (2019). Diagnosis and Management of Dementia: Review. JAMA, 322(16), 1589–1599. https://doi.org/10.1001/jama.2019.4782
[9]. Hung, C. C , Chang, C. C , Huang, C. W , Nouchi, R , & Cheng, C. H. (2022). Gut microbiota in patients with Alzheimer's disease spectrum: a systematic review and meta-analysis. Aging, 14(1), 477–496. https://doi.org/10.18632/aging.203826
[10]. Pluta, R , Ułamek-Kozioł, M , Januszewski, S , & Czuczwar, S. J. (2020). Gut microbiota and pro/prebiotics in Alzheimer's disease. Aging, 12(6), 5539–5550. https://doi.org/10.18632/aging.102930
[11]. Jäger, R , Mohr, A. E , Carpenter, K. C , Kerksick, C. M , Purpura, M , Moussa, A , Townsend, J. R , Lamprecht, M , West, N. P , Black, K , Gleeson, M , Pyne, D. B , Wells, S. D , Arent, S. M , Smith-Ryan, A. E , Kreider, R. B , Campbell, B. I , Bannock, L , Scheiman, J , Wissent, C. J , … Antonio, J. (2019). International Society of Sports Nutrition Position Stand: Probiotics. Journal of the International Society of Sports Nutrition, 16(1), 62. https://doi.org/10.1186/s12970-019-0329-0
[12]. Cattaneo, A , Cattane, N , Galluzzi, S , Provasi, S , Lopizzo, N , Festari, C , Ferrari, C , Guerra, U. P , Paghera, B , Muscio, C , Bianchetti, A , Volta, G. D , Turla, M , Cotelli, M. S , Gennuso, M , Prelle, A , Zanetti, O , Lussignoli, G , Mirabile, D , Bellandi, D , … INDIA-FBP Group (2017). Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of aging, 49, 60–68. https://doi.org/10.1016/j.neurobiolaging.2016.08.019
[13]. Hossain, S , Beydoun, M. A , Kuczmarski, M. F , Tajuddin, S , Evans, M. K , & Zonderman, A. B. (2019). The Interplay of Diet Quality and Alzheimer's Disease Genetic Risk Score in Relation to Cognitive Performance Among Urban African Americans. Nutrients, 11(9), 2181. https://doi.org/10.3390/nu11092181
[14]. Kim HI, Yun SW, Han MJ, Jang SE, Kim DH. IL-10 Expression-Inducing Gut Bacteria Alleviate High-Fat Diet-Induced Obesity and Hyperlipidemia in Mice. J. Microbiol. Biotechnol. 2020;30:599-603. https://doi.org/10.4014/jmb.1912.12014
[15]. Chang, P. V , Hao, L , Offermanns, S , & Medzhitov, R. (2014). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proceedings of the National Academy of Sciences of the United States of America, 111(6), 2247–2252. https://doi.org/10.1073/pnas.1322269111
[16]. Wong, J. M , de Souza, R , Kendall, C. W , Emam, A , & Jenkins, D. J. (2006). Colonic health: fermentation and short chain fatty acids. Journal of clinical gastroenterology, 40(3), 235–243. https://doi.org/10.1097/00004836-200603000-00015
[17]. Allin, K. H , Tremaroli, V , Caesar, R , Jensen, B. A. H , Damgaard, M. T. F , Bahl, M. I , Licht, T. R , Hansen, T. H , Nielsen, T , Dantoft, T. M , Linneberg, A , Jørgensen, T , Vestergaard, H , Kristiansen, K , Franks, P. W , IMI-DIRECT consortium, Hansen, T , Bäckhed, F , & Pedersen, O. (2018). Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia, 61(4), 810–820. https://doi.org/10.1007/s00125-018-4550-1
[18]. Silva, Y. P , Bernardi, A , & Frozza, R. L. (2020). The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in endocrinology, 11, 25. https://doi.org/10.3389/fendo.2020.00025
[19]. Barrett, E , Ross, R. P , O'Toole, P. W , Fitzgerald, G. F , & Stanton, C. (2012). γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of applied microbiology, 113(2), 411–417. https://doi.org/10.1111/j.1365-2672.2012.05344.x
[20]. Koh, A , De Vadder, F , Kovatcheva-Datchary, P , & Bäckhed, F. (2016). From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165(6), 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041
[21]. Underwood, M. A , German, J. B , Lebrilla, C. B , & Mills, D. A. (2015). Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatric research, 77(1-2), 229–235. https://doi.org/10.1038/pr.2014.156
[22]. Bonfili, L , Cecarini, V , Cuccioloni, M , Angeletti, M , Berardi, S , Scarpona, S , Rossi, G , & Eleuteri, A. M. (2018). SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model. Molecular neurobiology, 55(10), 7987–8000. https://doi.org/10.1007/s12035-018-0973-4
[23]. Mohajeri, M. H , La Fata, G , Steinert, R. E , & Weber, P. (2018). Relationship between the gut microbiome and brain function. Nutrition reviews, 76(7), 481–496. https://doi.org/10.1093/nutrit/nuy009
[24]. Thursby, E , & Juge, N. (2017). Introduction to the human gut microbiota. The Biochemical journal, 474(11), 1823–1836. https://doi.org/10.1042/BCJ20160510
[25]. Tanaka, M , & Nakayama, J. (2017). Development of the gut microbiota in infancy and its impact on health in later life. Allergology international : official journal of the Japanese Society of Allergology, 66(4), 515–522. https://doi.org/10.1016/j.alit.2017.07.010
[26]. Rinninella, E , Raoul, P , Cintoni, M , Franceschi, F , Miggiano, G. A. D , Gasbarrini, A , & Mele, M. C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7(1), 14. https://doi.org/10.3390/microorganisms7010014
[27]. Xu, C , Zhu, H , & Qiu, P. (2019). Aging progression of human gut microbiota. BMC microbiology, 19(1), 236. https://doi.org/10.1186/s12866-019-1616-2
[28]. Long, S. L , Gahan, C. G. M , & Joyce, S. A. (2017). Interactions between gut bacteria and bile in health and disease. Molecular aspects of medicine, 56, 54–65. https://doi.org/10.1016/j.mam.2017.06.002
[29]. Zheng, D , Liwinski, T , & Elinav, E. (2020). Interaction between microbiota and immunity in health and disease. Cell research, 30(6), 492–506. https://doi.org/10.1038/s41422-020-0332-7
[30]. Parkar, S. G , Kalsbeek, A , & Cheeseman, J. F. (2019). Potential Role for the Gut Microbiota in Modulating Host Circadian Rhythms and Metabolic Health. Microorganisms, 7(2), 41. https://doi.org/10.3390/microorganisms7020041
[31]. LeBlanc, J. G , Chain, F , Martín, R , Bermúdez-Humarán, L. G , Courau, S , & Langella, P. (2017). Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microbial cell factories, 16(1), 79. https://doi.org/10.1186/s12934-017-0691-z
[32]. Rowland, I , Gibson, G , Heinken, A , Scott, K , Swann, J , Thiele, I , & Tuohy, K. (2018). Gut microbiota functions: metabolism of nutrients and other food components. European journal of nutrition, 57(1), 1–24. https://doi.org/10.1007/s00394-017-1445-8
[33]. Li, Z , Quan, G , Jiang, X , Yang, Y , Ding, X , Zhang, D , Wang, X , Hardwidge, P. R , Ren, W , & Zhu, G. (2018). Effects of Metabolites Derived From Gut Microbiota and Hosts on Pathogens. Frontiers in cellular and infection microbiology, 8, 314. https://doi.org/10.3389/fcimb.2018.00314
[34]. Faulin, T. D. E. S , & Estadella, D. (2023). ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS. Arquivos de gastroenterologia, 60(1), 144–154. https://doi.org/10.1590/S0004-2803.202301000-17
[35]. Bonaz, B , Bazin, T , & Pellissier, S. (2018). The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Frontiers in neuroscience, 12, 49. https://doi.org/10.3389/fnins.2018.00049
[36]. Kuwahara, A , Matsuda, K , Kuwahara, Y , Asano, S , Inui, T , & Marunaka, Y. (2020). Microbiota-gut-brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system. Biomedical research (Tokyo, Japan), 41(5), 199–216. https://doi.org/10.2220/biomedres.41.199
[37]. Woźniak, D , Cichy, W , Przysławski, J , & Drzymała-Czyż, S. (2021). The role of microbiota and enteroendocrine cells in maintaining homeostasis in the human digestive tract. Advances in medical sciences, 66(2), 284–292. https://doi.org/10.1016/j.advms.2021.05.003
[38]. Cryan, J. F , O'Riordan, K. J , Cowan, C. S. M , Sandhu, K. V , Bastiaanssen, T. F. S , Boehme, M , Codagnone, M. G , Cussotto, S , Fulling, C , Golubeva, A. V , Guzzetta, K. E , Jaggar, M , Long-Smith, C. M , Lyte, J. M , Martin, J. A , Molinero-Perez, A , Moloney, G , Morelli, E , Morillas, E , O'Connor, R , … Dinan, T. G. (2019). The Microbiota-Gut-Brain Axis. Physiological reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018
[39]. Strandwitz P. (2018). Neurotransmitter modulation by the gut microbiota. Brain research, 1693(Pt B), 128–133. https://doi.org/10.1016/j.brainres.2018.03.015
[40]. Rothhammer, V , Borucki, D. M , Tjon, E. C , Takenaka, M. C , Chao, C. C , Ardura-Fabregat, A , de Lima, K. A , Gutiérrez-Vázquez, C , Hewson, P , Staszewski, O , Blain, M , Healy, L , Neziraj, T , Borio, M , Wheeler, M , Dragin, L. L , Laplaud, D. A , Antel, J , Alvarez, J. I , Prinz, M , … Quintana, F. J. (2018). Microglial control of astrocytes in response to microbial metabolites. Nature, 557(7707), 724–728. https://doi.org/10.1038/s41586-018-0119-x
[41]. Bonfili, L , Cecarini, V , Berardi, S , Scarpona, S , Suchodolski, J. S , Nasuti, C , Fiorini, D , Boarelli, M. C , Rossi, G , & Eleuteri, A. M. (2017). Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Scientific reports, 7(1), 2426. https://doi.org/10.1038/s41598-017-02587-2
[42]. Bonfili, L , Cecarini, V , Cuccioloni, M , Angeletti, M , Berardi, S , Scarpona, S , Rossi, G , & Eleuteri, A. M. (2018). SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model. Molecular neurobiology, 55(10), 7987–8000. https://doi.org/10.1007/s12035-018-0973-4
[43]. Kobayashi, Y , Sugahara, H , Shimada, K. et al. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease. Sci Rep 7, 13510 (2017). https://doi.org/10.1038/s41598-017-13368-2
[44]. Yang, X , Yu, D , Xue, L , Li, H , & Du, J. (2020). Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta pharmaceutica Sinica. B, 10(3), 475–487. https://doi.org/10.1016/j.apsb.2019.07.001
[45]. Nimgampalle, M , & Kuna, Y. (2017). Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats. Journal of clinical and diagnostic research : JCDR, 11(8), KC01–KC05. https://doi.org/10.7860/JCDR/2017/26106.10428
[46]. Agahi, A , Hamidi, G. A , Daneshvar, R , Hamdieh, M , Soheili, M , Alinaghipour, A , Esmaeili Taba, S. M , & Salami, M. (2018). Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial. Frontiers in neurology, 9, 662. https://doi.org/10.3389/fneur.2018.00662
[47]. Tamtaji, O. R , Heidari-Soureshjani, R , Mirhosseini, N , Kouchaki, E , Bahmani, F , Aghadavod, E , Tajabadi-Ebrahimi, M , & Asemi, Z. (2019). Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial. Clinical nutrition (Edinburgh, Scotland), 38(6), 2569–2575. https://doi.org/10.1016/j.clnu.2018.11.034
[48]. Kim, C. S , Cha, L , Sim, M , Jung, S , Chun, W. Y , Baik, H. W , & Shin, D. M. (2021). Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(1), 32–40. https://doi.org/10.1093/gerona/glaa090
[49]. Boyle, R. J , Robins-Browne, R. M , & Tang, M. L. (2006). Probiotic use in clinical practice: what are the risks?. The American journal of clinical nutrition, 83(6), 1256–1447. https://doi.org/10.1093/ajcn/83.6.1256
[50]. Teshale, A. Bacterial Probiotics their Importances and Limitations: A Review. https://doi.org/10.15744/2393-9060.4.202
[51]. Arora, K , Green, M , & Prakash, S. (2020). The Microbiome and Alzheimer's Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations. Frontiers in bioengineering and biotechnology, 8, 537847. https://doi.org/10.3389/fbioe.2020.537847
[52]. Feeney S. N. (2007). “Serotonin Syndrome,” in Pediatric Clinical Advisor, 2nd Edn, eds Garfunkel L. C , Kaczorowski J. M , Christy C. (Philadelphia, PA: Mosby; ), 516–517. 10.1016/B978-032303506-4.10295-0
[53]. Twarowski, B , & Herbet, M. (2023). Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review. International journal of molecular sciences, 24(7), 6518. https://doi.org/10.3390/ijms24076518
[54].Tangaro, S , Amoroso, N , Boccardi, M , Bruno, S , Chincarini, A , Ferraro, G , Frisoni, G. B , Maglietta, R , Redolfi, A , Rei, L , Tateo, A , Bellotti, R , & Alzheimers Disease Neuroimaging Initiative (2014). Automated voxel-by-voxel tissue classification for hippocampal segmentation: methods and validation. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 30(8), 878–887. https://doi.org/10.1016/j.ejmp.2014.06.044
[55]. Thakur AK, Kamboj P, Goswami K. Pathophysiology and management of alzheimer’s disease: an overview. J Anal Pharm Res. 2018;9(2):226?235. DOI: 10.15406/japlr.2018.07.00230
[56]. Mitra, A , & Sarkar, N. (2020). Sequence and structure-based peptides as potent amyloid inhibitors: A review. Archives of biochemistry and biophysics, 695, 108614. https://doi.org/10.1016/j.abb.2020.108614
[57]. Hamley I. W. (2012). The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Chemical reviews, 112(10), 5147–5192. https://doi.org/10.1021/cr3000994
[58]. Hou, J. T , Yu, K. K , Sunwoo, K , Kim, W. Y , Koo, S , Wang, J , Ren, W. X , Wang, S , Yu, X. Q , & Kim, J. S. (2020). Fluorescent Imaging of Reactive Oxygen and Nitrogen Species Associated with Pathophysiological Processes. Chem, 6(4), 832-866. https://doi.org/10.1016/j.chempr.2019.12.005
[59]. Ge, M , Zhang, J , Chen, S , Huang, Y , Chen, W , He, L , & Zhang, Y. (2022). Role of Calcium Homeostasis in Alzheimer's Disease. Neuropsychiatric disease and treatment, 18, 487–498. https://doi.org/10.2147/NDT.S350939
[60]. Bennett, R. E , Robbins, A. B , Hu, M , Cao, X , Betensky, R. A , Clark, T , Das, S , & Hyman, B. T. (2018). Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 115(6), E1289–E1298. https://doi.org/10.1073/pnas.1710329115
[61]. Mesulam M. M. (2013). Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease. The Journal of comparative neurology, 521(18), 4124–4144. https://doi.org/10.1002/cne.23415
[62]. Zhang, L , Li, D , Cao, F , Xiao, W , Zhao, L , Ding, G , & Wang, Z. Z. (2018). Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations. Combinatorial chemistry & high throughput screening, 21(1), 41–49. https://doi.org/10.2174/1386207320666171123201910
[63]. Hampel, H , Mesulam, M. M , Cuello, A. C , Farlow, M. R , Giacobini, E , Grossberg, G. T , Khachaturian, A. S , Vergallo, A , Cavedo, E , Snyder, P. J , & Khachaturian, Z. S. (2018). The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain : a journal of neurology, 141(7), 1917–1933. https://doi.org/10.1093/brain/awy132
[64]. Dallé, E , Mabandla, M. V , & Daniels, W. M. U. (2020). Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease. Oxidative medicine and cellular longevity, 2020, 5756382. https://doi.org/10.1155/2020/5756382
[65]. Gatta, V , Mengod, G , Reale, M , & Tata, A. M. (2020). Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis. Biomedicines, 8(6), 153. https://doi.org/10.3390/biomedicines8060153
[66]. Vitanova, K. S , Stringer, K. M , Benitez, D. P , Brenton, J , & Cummings, D. M. (2019). Dementia associated with disorders of the basal ganglia. Journal of neuroscience research, 97(12), 1728–1741. https://doi.org/10.1002/jnr.24508
[67]. Lebois, E.P , Thorn, C.A , Edgerton, J.R , Popiolek, M , & Xi, S. (2017). Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease. Neuropharmacology, 136, 362-373.
[68]. Heppner, F , Ransohoff, R. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16, 358–372 (2015). https://doi.org/10.1038/nrn3880
[69]. Sienski, G , Narayan, P , Bonner, J. M , Kory, N , Boland, S , Arczewska, A. A , Ralvenius, W. T , Akay, L , Lockshin, E , He, L , Milo, B , Graziosi, A , Baru, V , Lewis, C. A , Kellis, M , Sabatini, D. M , Tsai, L. H , & Lindquist, S. (2021). APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Science translational medicine, 13(583), eaaz4564. https://doi.org/10.1126/scitranslmed.aaz4564
[70]. Giau, V. V , Bagyinszky, E , Youn, Y. C , An, S. S. A , & Kim, S. (2019). APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease. International journal of molecular sciences, 20(19), 4757. https://doi.org/10.3390/ijms20194757
[71]. Zhang, D , Li, Y , Heims-Waldron, D , Bezzerides, V , Guatimosim, S , Guo, Y , Gu, F , Zhou, P , Lin, Z , Ma, Q , Liu, J , Wang, D. Z , & Pu, W. T. (2018). Mitochondrial Cardiomyopathy Caused by Elevated Reactive Oxygen Species and Impaired Cardiomyocyte Proliferation. Circulation research, 122(1), 74–87. https://doi.org/10.1161/CIRCRESAHA.117.311349
[72]. Giorgi, C , Marchi, S , Simoes, I. C. M , Ren, Z , Morciano, G , Perrone, M , Patalas-Krawczyk, P , Borchard, S , Jędrak, P , Pierzynowska, K , Szymański, J , Wang, D. Q , Portincasa, P , Węgrzyn, G , Zischka, H , Dobrzyn, P , Bonora, M , Duszynski, J , Rimessi, A , Karkucinska-Wieckowska, A , … Wieckowski, M. R. (2018). Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases. International review of cell and molecular biology, 340, 209–344. https://doi.org/10.1016/bs.ircmb.2018.05.006
[73]. Gowda, P , Reddy, P. H , & Kumar, S. (2022). Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria. Ageing research reviews, 73, 101529. https://doi.org/10.1016/j.arr.2021.101529
[74]. Huang, Y. R , & Liu, R. T. (2020). The Toxicity and Polymorphism of β-Amyloid Oligomers. International journal of molecular sciences, 21(12), 4477. https://doi.org/10.3390/ijms21124477
[75]. Song, L. L , Qu, Y. Q , Tang, Y. P , Chen, X , Lo, H. H , Qu, L. Q , Yun, Y. X , Wong, V. K. W , Zhang, R. L , Wang, H. M , Liu, M. H , Zhang, W , Zhang, H. X , Chan, J. T. W , Wang, C. R , Wu, J. H , & Law, B. Y. K. (2023). Hyperoside alleviates toxicity of β-amyloid via endoplasmic reticulum-mitochondrial calcium signal transduction cascade in APP/PS1 double transgenic Alzheimer's disease mice. Redox biology, 61, 102637. https://doi.org/10.1016/j.redox.2023.102637
[76]. Milane, L , Dolare, S , Jahan, T , & Amiji, M. (2021). Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines. Nanomedicine : nanotechnology, biology, and medicine, 37, 102422. https://doi.org/10.1016/j.nano.2021.102422
[77]. Sun, Y , Sommerville, N. R , Liu, J. Y. H , Ngan, M. P , Poon, D , Ponomarev, E. D , Lu, Z , Kung, J. S. C , & Rudd, J. A. (2020). Intra-gastrointestinal amyloid-β1-42 oligomers perturb enteric function and induce Alzheimer's disease pathology. The Journal of physiology, 598(19), 4209–4223. https://doi.org/10.1113/JP279919
[78]. Megur, A , Baltriukienė, D , Bukelskienė, V , & Burokas, A. (2020). The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?. Nutrients, 13(1), 37. https://doi.org/10.3390/nu13010037
[79]. Friedland R. P. (2015). Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. Journal of Alzheimer's disease : JAD, 45(2), 349–362. https://doi.org/10.3233/JAD-142841
[80]. Kobayashi, T , Suzuki, T , Kaji, R , Serata, M , Nagata, T , Ando, M , Iizuka, R , Tsujibe, S , Murakami, J , Kiyoshima-Shibata, J , Kato, I , Nanno, M , & Shida, K. (2012). Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models. Immunopharmacology and immunotoxicology, 34(3), 423–433. https://doi.org/10.3109/08923973.2010.617755
[81]. Akbari, E , Asemi, Z , Daneshvar Kakhaki, R , Bahmani, F , Kouchaki, E , Tamtaji, O. R , Hamidi, G. A , & Salami, M. (2016). Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Frontiers in aging neuroscience, 8, 256. https://doi.org/10.3389/fnagi.2016.00256
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mateusz Banasik, Aleksandra Adamczyk, Maria Ważny, Agnieszka Gancarz, Agata Żak, Michał Gut, Joanna Toporowska-Kaźmierak, Marta Sowińska, Miłosz Tworek, Damian Bezara
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 104
Number of citations: 0
